Microenvironment Proteinases, Proteinase-Activated Receptor Regulation, Cancer and Inflammation Publisher Pubmed



Eftekhari R^{1, 2} ; De Lima SG¹ ; Liu Y¹ ; Mihara K¹ ; Saifeddine M¹ ; Noorbakhsh F² ; Scarisbrick IA³ ; Hollenberg MD¹ Show Affiliations
Source: Biological Chemistry Published:2018

Abstract

We propose that in the microenvironment of inflammatory tissues, including tumours, extracellular proteinases can modulate cell signalling in part by regulating proteinase-activated receptors (PARs). We have been exploring this mechanism in a variety of inflammation and tumour-related settings that include tumour-derived cultured cells from prostate and bladder cancer, as well as immune inflammatory cells that are involved in the pathology of inflammatory diseases including multiple sclerosis. Our work showed that proteinase signalling via the PARs affects prostate and bladder cancer-derived tumour cell behaviour and can regulate calcium signalling in human T-cell and macrophage-related inflammatory cells as well as in murine splenocytes. Further, we found that the tumour-derived prostate cancer cells and immune-related cells (Jurkat, THP1, mouse splenocytes) can produce PAR-regulating proteinases (including kallikreins: kallikrein-related peptidases), that can control tissue function by both a paracrine and autocrine mechanism. We suggest that this PAR-driven signalling process involving secreted microenvironment proteinases can play a key role in cancer and inflammatory diseases including multiple sclerosis. © 2018 Walter de Gruyter GmbH, Berlin/Boston.